Semilunar Valve Function After Rejection in Heart Transplant Recipients: Implications for Partial Heart Transplantation
Pediatric Transplantation · 2025-08 · 29 (5)
DOI: 10.1111/petr.70123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Transplantation, online erschienen am 25.06.2025. Verfasst von Sarah Dudley und 3 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Cardiology, University of Virginia Children's Hospital, Charlottesville, Virginia, USA. Hauptthemen laut MEDLINE: Heart Transplantation, Graft Rejection, Heart Valve Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Partial heart transplantation (PHT) is a promising procedure for pediatric patients with irreparable semilunar valve disease. Current immunosuppression regimens mirror orthotopic heart transplant (OHT) protocols. However, semilunar valves may have immune privilege, making true immunosuppressive requirements unclear. This study examines the effect of rejection on semilunar valves in OHT to inform immunosuppression strategies for PHT.
Methods
We conducted a single‐center retrospective case–control study of pediatric OHT recipients from 2008 to 2023. Patients were grouped by the presence or absence of rejection episodes, with further stratification by rejection severity. Semilunar valve function was assessed via echocardiography at baseline, during, and after rejection episodes. Subgroup analysis was performed based on rejection severity and age at transplant (< 1 year of age).
Results
Of 113 eligible OHT recipients, 57 had ≥ 1 rejection episodes (32 high‐grade). Baseline valve function was comparable between rejection and non‐rejection groups. After a 3.8‐year median follow‐up, there were no significant differences in aortic or pulmonary valve gradients or in the prevalence of clinically significant regurgitation between groups. Paired analysis during rejection demonstrated no change in valve function compared to pre‐rejection assessment. Similar findings were observed in infants transplanted < 1 year of age.
Conclusions
Over a median follow up of nearly 4 years, semilunar valve function in pediatric OHT recipients remained clinically unaffected by rejection, even in high‐grade cases and among younger patients. These findings support the hypothesis of semilunar valve immune privilege and suggest that intensive immunosuppression may not be necessary to preserve valve function after PHT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pediatric Cardiology, University of Virginia Children's Hospital, Charlottesville, Virginia, USA.
- Department of Statistics, University of Virginia, Charlottesville, Virginia, USA.
ORCID-Profile: Sarah Dudley, Mark Conaway, Michael McCulloch, Firezer Haregu
Zitieren
APA
Dudley, S., Conaway, M., McCulloch, M., & Haregu, F. (2025). Semilunar Valve Function After Rejection in Heart Transplant Recipients: Implications for Partial Heart Transplantation. Pediatric Transplantation, 29(5). https://doi.org/10.1111/petr.70123
Vancouver
Dudley S, Conaway M, McCulloch M, Haregu F. Semilunar Valve Function After Rejection in Heart Transplant Recipients: Implications for Partial Heart Transplantation. Pediatric Transplantation. 2025;29(5). doi:10.1111/petr.70123
BibTeX
@article{Dudley2025,
author = {Dudley, Sarah and Conaway, Mark and McCulloch, Michael and Haregu, Firezer},
title = {Semilunar Valve Function After Rejection in Heart Transplant Recipients: Implications for Partial Heart Transplantation},
journal = {Pediatric Transplantation},
year = {2025},
volume = {29},
number = {5},
doi = {10.1111/petr.70123}
}
EUVIMED